Close
CDMO Safety Testing 2026
Novotech

PharmaLex strengthens Healthcare Compliance services

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...
- Advertisement -

PharmaLex Group, one of the most experienced and most successful specialist providers of Development Consulting, Regulatory Affairs, Pharmacovigilance, Epidemiology & Risk Management, and Quality Management & Compliance worldwide, have completed the merger with CompliMed in the United Kingdom.

CompliMed is the UKโ€™s leading Healthcare Compliance Consultancy specialising in the ABPI Code of Practice. Their services include training, e-learning, outsourcing, audits, SOPs, medical review and final signatory support.

By joining forces with CompliMed, PharmaLex will extend its services in healthcare compliance, further enabling its customers to maximise promotional effectiveness whilst complying with legislation and codes of practice during their engagements with healthcare professionals, the public and patients. This will provide a strategic fit where PharmaLex already acts as medical reviewer, Information Officer or certifying signatory in line with national requirements in European countries.

โ€œThe merger with PharmaLex is a major milestone for CompliMedโ€, explained Dr. Rina Newton, Managing Director, CompliMed. โ€œWe are excited to be able to strengthen the services they offer as we become part of a larger organization with an excellent reputation and significant global footprintโ€, she added.

โ€œCompliMed are a perfect fit for PharmaLexโ€, explained Dr Thomas Dobmeyer, CEO PharmaLex. โ€œOur strategy is to build a European service line that offers healthcare compliance in all European countries and the US. CompliMed are trusted by their customers for their high-quality standards. Having such a dependable team join PharmaLex is a real asset as both organisations are committed to outstanding service levels and delivering exceptional client solutionsโ€, he added.

About PharmaLex

PharmaLex is one of the largest providers of specialist services for Development Consulting, Regulatory Affairs, Quality Management & Compliance and Pharmacovigilance, Epidemiology and Risk Management worldwide. Our global teams of experts can take you through early strategic planning activities and non-clinical requirements to clinical development, through regulatory submission processes and finally guide you to market approval and product maintenance post-launch activities. We strive to deliver exceptional results โ€” going above and beyond the standard to deliver tailor-made solutions. We aim to exceed your expectations and live by our values โ€“ flexibility, efficiency, passion and dedication.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป